GlassScriptPhysician profile
Noman Saif
NPI 1669426375
$3,098.68
in general payments reported to CMS, 2019-2025
19 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,417 · 2020: $92.98 · 2021: $492 · 2022: $324 · 2023: $197 · 2024: $213 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $818.32 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $302.14 | 2021-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $258.24 | 2019-2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $233.67 | 2019-2021 | |
| Insulet Corporation | $208.79 | 2021-2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.60 | 2019-2023 | Synjardy, Jardiance |
| Corcept Therapeutics | $168.54 | 2019-2025 | Korlym |
| Amgen INC. | $146.99 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $135.75 | 2019-2020 | |
| Mannkind Corporation | $115.69 | 2019 | |
| Medtronic, INC. | $109.04 | 2021-2025 | Minimed 780g |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.74 | 2019 | |
| Alexion Pharmaceuticals, INC. | $84.22 | 2025 | Strensiq |
| Bayer Healthcare Pharmaceuticals INC. | $84.02 | 2022-2023 | |
| Radius Health, INC. | $50.56 | 2025 | Tymlos |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $30.64 | 2019-2020 | |
| Dexcom, INC. | $18.46 | 2021 | |
| Xeris Pharmaceuticals, INC. | $16.37 | 2024 | Gvoke Hypopen |
| Medtronic Minimed, INC. | $15.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noman Saif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.